Mexico BE – add-on design? [Regulatives / Guidelines]

posted by nobody – 2014-10-24 10:46 (3795 d 22:18 ago) – Posting: # 13794
Views: 8,371

Hi Risherd!

Nice to meet you, even if it's only on the virtual level!

Good to know that I'm not alone searching for the modified release guidance.

Even better to know that the guidance is a law (must be a law, I guess, otherwise no way to demand performing BE trials inside Mexico), I had some guys wanting to change the model for ANOVA, gives me even more arguments for sticking to the approach given in the guideline. :-D

In general the Mexican guidance is straight forward regarding various topics, but this add-on gives me some headaches. Do you have any experience on that? Does it have to be proposed in the initial protocol? Guess: yes, otherwise no way to preserve the consumer risk. Which statistics are accepted to keep the consumers risk at 5%?

Would be very interesting to know!

Best regards (rain, 9°C, brrrrr...)

nobody

Kindest regards, nobody

Complete thread:

UA Flag
Activity
 Admin contact
23,409 posts in 4,921 threads, 1,667 registered users;
60 visitors (0 registered, 60 guests [including 11 identified bots]).
Forum time: 08:05 CET (Europe/Vienna)

They must find it difficult…; those who have taken authority as the truth,
rather than truth as the authority.    Gerald Massey

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5